NCT07515508 Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
| NCT ID | NCT07515508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Heart Center Freiburg - Bad Krozingen |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-08-07 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2024-08-07 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doctors better identify different types of cardiogenic shock and better predict outcomes in adults hospitalized with acute heart failure and cardiogenic shock. The main question is whether clinical findings, imaging results, and biomarkers, including sex-specific factors, are associated with the risk of death within 30 days. Participants will not receive an experimental treatment. Researchers will collect data from routine care, collect additional blood and urine samples for biobanking, and follow participants after hospital discharge
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized with acute heart failure SCAI stage B - E. Exclusion Criteria: * Not capable of providing informed consent due to reasons not attributable to cardiogenic shock * Cardiogenic shock following cardiothoracic surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07515508 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07515508 currently recruiting?
Yes, NCT07515508 is actively recruiting participants. Contact the research team at lucas.bacmeister@uniklinik-freiburg.de for enrollment information.
Where is the NCT07515508 trial being conducted?
This trial is being conducted at Bad Krozingen, Germany, Freiburg im Breisgau, Germany, Nuremberg, Germany, Villingen-Schwenningen, Germany.
Who is sponsoring the NCT07515508 clinical trial?
NCT07515508 is sponsored by University Heart Center Freiburg - Bad Krozingen. The trial plans to enroll 600 participants.